Spire Healthcare and a consortium of funds including Toscafund, Three Hills and Ares, have reached an agreement on the terms of a recommended cash offer of 250 pence, valuing Spire’s issued share capital at approximately £1.0265bn (US$1.39bn) and implying an enterprise value of approximately £2.3076bn.
The price represents an implied...
Cureety, a France-based precision oncology care company, has acquired Reimagine Care, a US company combining AI-powered cancer care support with oncology-specialised care teams to extend cancer care beyond the clinic. Reimagine Care is already working with leading cancer centres and healthcare networks across the US.
“Cancer treatment has become extraordinarily precise, and we have an opportunity to bring that same level of precision to the care surrounding it,” said François-Guirec Champoiseau, CEO and co-founder of Cureety. “Together, we can understand what therapy a patient is receiving, what risks matter for...